Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06846398 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Shanghai Argo Biopharmaceutical Co., Ltd. |
| Last Updated on CT.gov | August 29, 2025 (Aug 29, 2025) |
As of March 2, 2026: Clinical trial NCT06846398 is currently recruiting participants. This clinical trial study for hereditary angioedema is actively seeking new participants at 5 locations across the United States. The study is sponsored by Shanghai Argo Biopharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06846398 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06846398 was last updated Aug 29, 2025 (August 29, 2025). HelloStudys verifies this status automatically.